3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
6
Active not recruiting
5
Recruiting
3
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
51
Breast Neoplasms
40
Colorectal Neoplasms
26
Prostatic Neoplasms
22
Lung Neoplasms
18
Carcinoma, Non-Small-Cell Lung
15
Carcinoma, Hepatocellular
15
Stomach Neoplasms
14
Hematologic Neoplasms
10
Brain Neoplasms
10
Pancreatic Neoplasms
9
Colonic Neoplasms
9
Urinary Bladder Neoplasms
8
Lymphoma, Follicular
8
Head and Neck Neoplasms
8
Uterine Cervical Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Ovarian Neoplasms
7
Melanoma
7
Liver Neoplasms
7
Leukemia, Myeloid, Acute
7
Disease
7
Anxiety Disorders
7
Myasthenia Gravis
6
Multiple Myeloma
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Rectal Neoplasms
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Neurotoxicity Syndromes
×
1 year
×
Clear all
NCT06950190
2025-08-12
(ECCPC)
Ellis Medicine
Phase 3
Enrolling by invitation
100 enrolled